Plastic and reconstructive surgery · 2024
A Quantitative Evaluation of the Effects of Radiation Therapy on the Postsurgical Breast.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Becker Miriam, Reese McKay, Yessaillian Andrea, Lopes Kelli, Harfouche Cyril, Leach Garrison, Blair Sarah, Yashar Catheryn, Ojeda-Fournier Haydee, Reid Chris M
Аннотация
BACKGROUND: Radiation therapy (RT) effects on breast volume may affect breast-conserving therapy (BCT) outcomes, but quantitative information is lacking regarding the extent and timing of volume loss. This study aimed to quantify volume loss by assessing changes in irradiated breasts.
METHODS: Breast volume changes were calculated for 113 patients (115 breasts) after T1 tumor lumpectomies. From preoperative baseline to 7 years after radiation, volumes were calculated from mammograms using the formula π/3 * height * radius 2 . Paired t tests assessed change over time, with subset analyses of tumor and breast volumes of 10% or less ( n = 67) and greater than 10% ( n = 48). Multivariable regression assessed volume change as a function of age, smoking history, diabetes, radiation dosage, fractions, technique, treatment length, boost dose, chemotherapy (hormonal or cytotoxic), baseline breast volume, and time since treatment.
RESULTS: Patients lost 8.3% of breast volume during surgery. One year after BCT/RT, volume loss was 19.3%. By year 5, total volume loss was 26.6%. Subset analyses demonstrated that in addition to lumpectomy defects, 5-year volume loss was 21.7% for tumor/breast volume greater than 10% and 29.5% for tumor/breast volume of 10% or less. Volume loss between subgroups was not significantly different ( P = 0.37). Larger breast volume was a significant predictor of greater volume loss for all 5 years ( P < 0.001), followed by diabetes and smoking history.
CONCLUSIONS: Patients with T1 tumors undergoing BCT/RT may lose approximately 20% of breast volume (beyond specimens) within a year, with continued loss for 5 years. Volume change did not differ significantly according to baseline breast volume, although larger breasts may experience comparatively larger volume changes.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
METHODS: Breast volume changes were calculated for 113 patients (115 breasts) after T1 tumor lumpectomies. From preoperative baseline to 7 years after radiation, volumes were calculated from mammograms using the formula π/3 * height * radius 2 . Paired t tests assessed change over time, with subset analyses of tumor and breast volumes of 10% or less ( n = 67) and greater than 10% ( n = 48). Multivariable regression assessed volume change as a function of age, smoking history, diabetes, radiation dosage, fractions, technique, treatment length, boost dose, chemotherapy (hormonal or cytotoxic), baseline breast volume, and time since treatment.
RESULTS: Patients lost 8.3% of breast volume during surgery. One year after BCT/RT, volume loss was 19.3%. By year 5, total volume loss was 26.6%. Subset analyses demonstrated that in addition to lumpectomy defects, 5-year volume loss was 21.7% for tumor/breast volume greater than 10% and 29.5% for tumor/breast volume of 10% or less. Volume loss between subgroups was not significantly different ( P = 0.37). Larger breast volume was a significant predictor of greater volume loss for all 5 years ( P < 0.001), followed by diabetes and smoking history.
CONCLUSIONS: Patients with T1 tumors undergoing BCT/RT may lose approximately 20% of breast volume (beyond specimens) within a year, with continued loss for 5 years. Volume change did not differ significantly according to baseline breast volume, although larger breasts may experience comparatively larger volume changes.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.